Global AI for Cancer Diagnosis Market Growth (Status and Outlook) 2023-2029

Global AI for Cancer Diagnosis Market Growth (Status and Outlook) 2023-2029

The global AI for Cancer Diagnosis market size is projected to grow from US$ 129.6 million in 2022 to US$ 1051.4 million in 2029; it is expected to grow at a CAGR of 34.9% from 2023 to 2029.

United States market for AI for Cancer Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for AI for Cancer Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for AI for Cancer Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key AI for Cancer Diagnosis players cover Lunit Inc, Xilis, Shukun Technology, Kheiron, SkinVision, Infervision, Imagene AI, Oncora Medical and Niramai Health Analytix, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “AI for Cancer Diagnosis Industry Forecast” looks at past sales and reviews total world AI for Cancer Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected AI for Cancer Diagnosis sales for 2023 through 2029. With AI for Cancer Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI for Cancer Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global AI for Cancer Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI for Cancer Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI for Cancer Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI for Cancer Diagnosis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI for Cancer Diagnosis.

This report presents a comprehensive overview, market shares, and growth opportunities of AI for Cancer Diagnosis market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Breast Cancer
Lung Cancer
Prostatic Cancer
Others

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lunit Inc
Xilis
Shukun Technology
Kheiron
SkinVision
Infervision
Imagene AI
Oncora Medical
Niramai Health Analytix
Enlitic
Maxwell Plus
Therapixel
Ibex
OrigiMed
Tencent

Please note: the online download version of this report is for a global site license.